880652-44-8Relevant articles and documents
SHMT Inhibitors
-
Paragraph 0512-0514, (2018/03/25)
The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmune disorders.
NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS
-
, (2013/09/12)
The present invention relates to a compound according to formula (A) wherein n is 1 or 2; R1 and R2 are independently hydrogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, CD3 or halogen; R3 is hydrogen, C(=O)OR7 or C1-4 alkyl optionally substituted with hyd
Alkynyl compounds as non nucleoside reverse transcriptase inhibitors
-
Page/Page column 18, (2010/10/20)
Inhibitors of HIV reverse transcriptase which are useful for the treatment of HIV infection. Exemplars of the invention are compounds of the formula wherein the substituents are as defined in the following table. R1R2R4Rs